Skip to content

Epithalon

Preclinical only

Tetrapeptide (Ala-Glu-Asp-Gly) studied for potential telomere and longevity effects. Not medical advice; consult a provider.

How Epithalon works

Epithalon has been studied for telomerase activation and antioxidant effects. Human evidence is limited; use only with provider guidance and continued research.

Researched benefits

  • •Research in cellular aging and telomere length
  • •Antioxidant and neuroprotective studies
  • •Longevity research in model systems

What it is studied for

  • •Aging and longevity research
  • •Sleep and melatonin modulation in some studies
  • •Combination in longevity protocols

Reported side effects and cautions

  • •Limited human safety data
  • •Long-term effects unknown

Dosing protocol described in the literature

Dosage
5-10mg
Frequency
Cyclic
Administration
Subcutaneous
Cycle
2-3 weeks on, 2-3 months off

Longevity research

Work out the reconstitution for this dose →

Evidence rating: Preclinical only

Evidence comes from laboratory or animal research. Human safety and effectiveness have not been established.

Other peptides

BPC157TB500 (Thymosin B4 Acetate)Semaglutide (Ozempic / Wegovy)Tirzepatide (GLP-1/GIP dual agonist)CagrilintideRetatrutide + Cagrilintide (combination)

See every peptide in the library →

Educational information only. This page is not medical advice, not a prescription, and not a recommendation to use Epithalon. Dosing figures describe what appears in published research and provider protocols — they are not instructions. Several compounds covered here are prescription medicines. Talk to a licensed healthcare provider before acting on anything you read.